HONG KONG – The launch of the South African Health Products Regulatory Authority (SAHPRA) will have long-term implications for South Africa's pharmaceutical industry, but it will take time for domestic drugmakers to see tangible benefits.

HONG KONG – With increasing demand for drugs targeting chronic diseases in China, investment from multinational pharma giants is set to rise, leading to possible benefits for local firms as well. Much of the focus is likely to be on cancer.

HONG KONG – With increasing demand for drugs targeting chronic diseases in China, investment from multinational pharma giants is set to rise, leading to possible benefits for local firms as well. Much of the focus is likely to be on cancer.

HONG KONG – Cstone Pharmaceuticals Co. Ltd. has received the go-ahead from the CFDA to conduct clinical trials with its investigational agent, CS-1001, making it the first company in China to successfully have a fully human, full-length anti-PD-L1 monoclonal antibody enter clinical development.

GUANGZHOU, China – China's health care reforms have made great strides toward developing the country's pharmaceutical industry, but the current ecosystem may not be enough for China to compete on the world stage of drug development, said industry experts and regulators at this week's GF Securities Life Sciences Investment Conference.

GUANGZHOU, China – China's health care reforms have made great strides toward developing the country's pharmaceutical industry, but the current ecosystem may not be enough for China to compete on the world stage of drug development, said industry experts and regulators at this week's GF Securities Life Sciences Investment Conference.

HONG KONG – Sinovac Biotech Ltd., China's leading vaccine maker, is in the midst of a go-private transaction that has morphed into a heated bidding war.